Categories: BrainNeuroscienceNews

Eyesight Electronics Ltd Pioneers Breakthrough: Legally Blind Patient Regains Sight with New Hope for Lazy Eye Treatment

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MOTHERWELL, Scotland, April 23, 2025 /PRNewswire/ — A patient who was previously classified as legally blind has regained over 50% of their vision in just a few months, thanks to an innovative home-based treatment called AmblyoFix. Developed by a family-run Scottish start-up, this ground-breaking therapy is challenging traditional methods of treating amblyopia, commonly known as lazy eye.

Amblyopia affects over 100 million people worldwide, most of them children. If left untreated, it can lead to permanent vision impairment. Traditional treatments, such as eye patching, are slow, uncomfortable, and often ineffective, with only around 50% compliance among young patients.

But AmblyoFix changes everything. Designed by Eyesight Electronics, the therapy uses specially designed 3D glasses and interactive games to train the brain to process visual information from both eyes. Unlike patching, which blocks the strong eye to force the weak eye to work harder, AmblyoFix engages both eyes together – boosting depth perception, hand-eye coordination, and binocular vision.

In a recent clinical test, a patient who had 6/60 vision (legally blind in the USA) saw a 22% improvement in just 2.5 weeks, 40% after 9 weeks, and over 52% after 14 weeks. In comparison, leading VR-based treatments only showed around 18% improvement in the same timeframe.

More than a medical device, AmblyoFix is a story of passion and perseverance. The company was founded by Dr. Faiz Rigi, an ophthalmologist, and his son Amin Rigi, a bioengineer who recently completed his PhD viva at the University of Edinburgh. The idea came from a conversation between father and son about the most common eye condition with outdated treatment methods. The answer: amblyopia.

What started as a father-and-son project quickly became a family-led mission. With contributions from Amin’s brother, mother, sister, and wife, the startup grew into a global effort. Now, supported by engineers, designers, and developers, the company is ready to bring their solution to families worldwide.

AmblyoFix is also patent protected, with one US patent granted and another pending. The team has received multiple awards, including the IP Hatch award, which granted them a Panasonic patent in recognition of their innovation.

“We’re not just improving vision—we’re giving people their confidence, independence, and quality of life back,” says CEO Amin Rigi. “Our dream is to ensure no one loses sight to a treatable condition.”

About Eyesight Electronics Founded in 2019, Eyesight Electronics is a family-led health tech company developing advanced solutions for vision care. Their flagship product, AmblyoFix, is a clinically-backed, neuroscience-powered therapy for amblyopia.

Contact
Website: https://amblyofix.com
Email: info@amblyofix.com

Media Contact:
Safa Murad
+447999374379
393630@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/eyesight-electronics-ltd-pioneers-breakthrough-legally-blind-patient-regains-sight-with-new-hope-for-lazy-eye-treatment-302435303.html

SOURCE Eyesight Electronics Ltd

Staff

Recent Posts

Sectra’s year-end report 2024/2025: Reporting solid growth in a time of change

LINKÖPING, Sweden, June 5, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT…

1 hour ago

Beyond Medical Technologies Closes First Tranche of Convertible Note Financing for $1.68 Million and Announces Rebranding to Republic Technologies

Vancouver, British Columbia--(Newsfile Corp. - June 4, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT)…

13 hours ago

Vita Bella Joins Forces with DUPR as the Official Health and Wellness Partner of Competitive Pickleball

This strategic partnership is a bold move that brings peak performance to the pickleball court,…

13 hours ago

0602K + Tirzepatide Muscle Mass / Function and Adipose Transformation Data to be Presented at ADA Scientific Sessions

GRAND RAPIDS, Mich., June 4, 2025 /PRNewswire/ -- Cirius Therapeutics, Inc.,  developing innovative therapies for patients…

13 hours ago

Catalis Dental Lab Partners Expands National Presence with Acquisition of Revolution Dental Lab and Launch of East Coast Digital Design Center

SAVANNAH, Ga., June 3, 2025 /PRNewswire/ -- Catalis Dental Lab Partners ("Catalis") announced two significant…

13 hours ago

Blue Zones Project Citywide Kick-Off Event in Banning

BANNING, Calif., June 4, 2025 /PRNewswire/ -- Blue Zones Project invites the community to their…

13 hours ago